Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

This study was designed to retrospectively evaluate the efficacy and safety of modified FOLFOX-6 regimen in advanced gastric cancer (AGC) patients with poor performance status (PS). From January 2005 to August 2010, 23 AGC patients with poor PS who received mFOLFOX-6 as first-line chemotherapy were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: KIM, HYEONG SU, KIM, JUNG HAN, KIM, HEE JUN, JANG, HYUN JOO, KIM, JIN BAE, KIM, JI WON, JUNG, SO YOUNG, KIM, BYUNG CHUN, YANG, DAE HYUN, PARK, SOAH, KIM, KEONG JU, LEE, SOON IL, ZANG, DAE YOUNG
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362383/
https://ncbi.nlm.nih.gov/pubmed/22740925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.496
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados